Informações:
Falhas:
ID
31499
Descrição
Tolvaptan Phase 3 Efficacy and Safety Study in ADPKD; ODM derived from: https://clinicaltrials.gov/show/NCT00428948
Link
https://clinicaltrials.gov/show/NCT00428948
Palavras-chave
Versões (1)
- 28/08/2018 28/08/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
28 de agosto de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948
Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948
- StudyEvent: Eligibility
Similar models
Eligibility Polycystic Kidney Disease, Autosomal Dominant NCT00428948
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Estimated Glomerular Filtration Rate
Item
gfr estimated at ≥60 ml/ min
boolean
C3811844 (UMLS CUI [1])
Autosomal Dominant Polycystic Kidney Disease | Kidney Growth Rapidly progressive MRI | Kidney Total Volume MRI
Item
diagnosis of adpkd and rapidly progressive kidney growth (total volume ≥750 cc) by magnetic resonance imaging (mri) at randomization
boolean
C0085413 (UMLS CUI [1])
C0022646 (UMLS CUI [2,1])
C0018270 (UMLS CUI [2,2])
C1838681 (UMLS CUI [2,3])
C0024485 (UMLS CUI [2,4])
C0022646 (UMLS CUI [3,1])
C0449468 (UMLS CUI [3,2])
C0024485 (UMLS CUI [3,3])
C0022646 (UMLS CUI [2,1])
C0018270 (UMLS CUI [2,2])
C1838681 (UMLS CUI [2,3])
C0024485 (UMLS CUI [2,4])
C0022646 (UMLS CUI [3,1])
C0449468 (UMLS CUI [3,2])
C0024485 (UMLS CUI [3,3])
Legal Adult | Informed Consent
Item
legal adult age and able to give informed consent
boolean
C1706450 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [2])
Gender | Contraceptive methods Willing
Item
willingness to comply with reproductive precautions if female
boolean
C0079399 (UMLS CUI [1])
C0700589 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
Exposure to Tolvaptan | Exposure to Experimental Therapies Polycystic Kidney Diseases
Item
prior exposure to tolvaptan or other experimental pkd therapies
boolean
C0332157 (UMLS CUI [1,1])
C1176308 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0949266 (UMLS CUI [2,2])
C0022680 (UMLS CUI [2,3])
C1176308 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0949266 (UMLS CUI [2,2])
C0022680 (UMLS CUI [2,3])
Pharmaceutical Preparations Affecting PKD Cysts
Item
currently taking medication for purpose of affecting pkd cysts
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0022680 (UMLS CUI [1,3])
C0010709 (UMLS CUI [1,4])
C0392760 (UMLS CUI [1,2])
C0022680 (UMLS CUI [1,3])
C0010709 (UMLS CUI [1,4])
Breast Feeding | Childbearing Potential Contraceptive methods Absent
Item
women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
boolean
C0006147 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Safety Risk | Interference Study Protocol
Item
in the opinion of the study investigator or sponsor may present a safety risk or confound study objectives
boolean
C0036043 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0521102 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C0035647 (UMLS CUI [1,2])
C0521102 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Protocol Compliance Unlikely
Item
patients who are unlikely to adequately comply with study procedures
boolean
C0525058 (UMLS CUI [1,1])
C0750558 (UMLS CUI [1,2])
C0750558 (UMLS CUI [1,2])
Medical contraindication MRI
Item
patients having contraindications to mri
boolean
C1301624 (UMLS CUI [1,1])
C0024485 (UMLS CUI [1,2])
C0024485 (UMLS CUI [1,2])
Pharmaceutical Preparations Affecting Autosomal Dominant Polycystic Kidney Disease Outcome | Illness Affecting Autosomal Dominant Polycystic Kidney Disease Outcome
Item
patients taking medications or having any illnesses likely to affect adpkd outcomes.
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0085413 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,4])
C0221423 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0085413 (UMLS CUI [2,3])
C1274040 (UMLS CUI [2,4])
C0392760 (UMLS CUI [1,2])
C0085413 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,4])
C0221423 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0085413 (UMLS CUI [2,3])
C1274040 (UMLS CUI [2,4])